Keyphrases
Hematopoietic Cell Transplantation
100%
Frailty
100%
Pretransplant
100%
Cell Association
100%
Mental Distress
100%
Clinical Outcomes
100%
Hematopoietic Cell Transplant
64%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
58%
Confidence Interval
58%
Non-relapse Mortality
29%
Odds Ratio
29%
High Risk
17%
Multivariate Analysis
17%
Old Age
17%
Hazard Ratio
17%
Non-frail
17%
Hematological Malignancies
11%
Overall Survival
11%
Patient Health Questionnaire-9 (PHQ-9)
11%
Risk Factors
5%
Early Response
5%
Vulnerable Populations
5%
Healthcare Utilization
5%
Allogeneic
5%
Targeted Intervention
5%
Haematopoietic Stem Cell Transplant Recipients
5%
Adverse Effects
5%
Transplant Outcomes
5%
Frail Elderly
5%
Relapse Risk
5%
All Ages
5%
Age Groups
5%
Significant Risk Factors
5%
High Prevalence
5%
Logistic Regression Analysis
5%
Non-associated
5%
Baseline Characteristics
5%
Large Cohort
5%
Hospital Stay
5%
1-year Mortality
5%
Risk of Death
5%
Depression Score
5%
Mental Health Distress
5%
Assessment Intervention
5%
Aging Characteristics
5%
Physiological Reserve
5%
Transplant Evaluation
5%
Multidisciplinary Intervention
5%
Needs Investigation
5%
Fried Criteria
5%
Distress Screening
5%
Distress Indicators
5%
Frailty Domains
5%
Medicine and Dentistry
Hematopoietic Cell
100%
Cell Transplantation
100%
Prevalence
100%
Frailty
100%
Transplantation
77%
Odds Ratio
27%
Multivariate Analysis
16%
Hazard Ratio
16%
Hematologic Malignancy
11%
Overall Survival
11%
Patient Health Questionnaire 9
11%
Mental Health
5%
Adverse Event
5%
Vulnerable Population
5%
Logistic Regression Analysis
5%
Immunology and Microbiology
Cell Transplantation
100%
Prevalence
100%
Hematopoietic Cell
100%
Overall Survival
14%
Mental Health
7%
Vulnerable Population
7%
Psychology
Multivariate Analysis
100%
Hazard Ratio
100%
Mental Health
33%
Regression Analysis
33%
Mathematics
Confidence Interval
100%
Odds Ratio
50%
Hazard Ratio
30%
Multivariate Analysis
30%
Logistic Regression Analysis
10%
Hospital Stay
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Frailty
100%
Hematologic Malignancy
11%
Overall Survival
11%
Adverse Event
5%